OSSIO Inc. opened its U.S. headquarters Tuesday in the City of Palmetto, expanding its manufacturing and training presence in the Tampa Bay area.
The 30,000-square-foot facility houses both a product manufacturing plant and a surgeon training center.
The opening drew business leaders, healthcare executives and state officials, including Florida Lt. Gov. Jay Collins.
The Palmetto site now anchors OSSIO’s U.S. commercial operations, adding another advanced manufacturing employer to Tampa Bay’s growing life sciences sector.
Why OSSIO chose Tampa Bay
Founded in Israel in 2014, OSSIO develops bio-integrative, metal-free fixation implants used in orthopedic surgery.
CEO Brian Verrier said Florida offered the workforce depth and operating environment needed to support the company’s next phase of growth.
READ: TAMPA BAY BUSINESS NEWS
The decision places OSSIO among a growing group of companies in Tampa Bay expanding advanced manufacturing, medical technology and healthcare innovation.
“We couldn’t feel more welcome in Florida,” Verrier said following the ribbon-cutting. “Our future in the Sunshine State is clearly bright.”
Job growth and workforce impact
OSSIO expects to create about 100 jobs in Palmetto over the next five years.
Positions will span production, commercial and administrative roles, according to the company. Recruiting for the first openings began in January.
State leaders framed the expansion as part of Florida’s broader economic development strategy focused on high-skill industries.
READ: TAMPA BAY REAL ESTATE NEWS
“OSSIO’s decision to establish its U.S. headquarters here in Palmetto reflects Florida’s strong workforce, pro-growth environment and commitment to supporting advanced manufacturing and medical innovation,” Collins said in prepared remarks.
A surgeon training hub for the Gulf Coast
Beyond manufacturing, the headquarters is designed to function as a national training destination.
Verrier said OSSIO expects to bring hundreds of surgeons to the Tampa Bay Area each year for hands-on instruction using the company’s technology.
The recurring flow of visiting surgeons positions the facility as both an employer and an ongoing contributor to the local business economy.
“We’re very much looking forward to driving the company’s ambitious growth plans from our new U.S. headquarters,” Verrier said.
Strengthening Florida’s life sciences ecosystem
BioFlorida President and CEO Mark Glickman said OSSIO’s decision to locate manufacturing and training operations in Florida reflects confidence in the state’s life sciences ecosystem.
“The company’s decision to locate advanced manufacturing and surgeon training here speaks volumes about the depth of our talent and the strength of our life sciences ecosystem,” Glickman said.
READ: TAMPA BAY RAYS NEWS
Rakefet Bachur-Phillips, co-executive director of the Florida-Israel Business Accelerator, said the expansion also reinforces long-term economic ties between Florida and Israel.
“OSSIO’s expansion is a landmark moment for the Florida-Israel innovation corridor,” she said.
Company growth and technology adoption
According to OSSIO, more than 65,000 OSSIOFiber implants have been used to treat orthopedic patients in the U.S. through December 2025.
The company conducts product development in Caesarea, Israel with additional commercial operations in Palmetto and Woburn, Massachusetts.
The Palmetto headquarters positions OSSIO to scale manufacturing, training and workforce development as demand for orthopedic innovation continues to grow.
Why it matters for Tampa Bay business
The OSSIO expansion adds a new advanced manufacturing employer to Manatee County while reinforcing Tampa Bay’s role as a destination for healthcare innovation, workforce development and specialized professional training.
The combination of job creation and recurring surgeon traffic ties long-term economic impact to sustained operational activity rather than a one-time investment.
